Sentence examples for deployment of trials from inspiring English sources

77 One major challenge to the deployment of trials in the study of improvement is that improvement interventions may tend to mutate over time in response to learning, but much trial methodology is based on the assumption of a stable, well-defined intervention, and may not give sufficient recognition to the interchange between intervention and context.

This paper describes the design and deployment of a trial SIAM; an easily reproducible intervention that aims to reduce suicide risk in adults after self-harm.

The initial phases of the study are ongoing with concurrent concept development of the latter phases entailing identification, assessment and possible deployment of a field trial of detection and intervention approaches.

The clinical trial software configuration is used in the GORD use case and consists of components needed for design, deployment, and collection of trial data, backed by provenance and secure authentication framework for researchers.

The full deployment of the devices follows trials, which involved 28 police forces using technology developed under the Lantern programme to test how mobile fingerprinting performs in an operational environment.

The gulf between technology and the successful deployment of biomarkers in clinical trials is narrowing rapidly, although clinical pharmacology laboratories face significant challenges in implementing biomarker studies in early clinical trials (Cummings et al, 2004).

Both Verizon and SBC are engaged in trials and deployment of fiber optic networks, which offer significantly higher speeds than existing D.S.L. services.

According to Deloitte, more than 150 carriers in 60 countries are committed to the deployment or trial of 4G services.

Therefore, as an innovation project, VISOR is trialing the deployment of a dedicated VLF monitoring tool.

This study supports the continued deployment of circulating CK18 into biomarker-enhanced trials, particularly in patients undergoing chemotherapy for metastatic CRC.

This study provides evidence for cytokeratin 18 (CK18) as a prognostic and PD biomarker in patients with CRC and supports continued deployment of circulating CK18 in biomarker-enhanced trials.